Key antibodies used included: anti-FOXO4 (two different clones, ab128908 and sc-373877), anti-StAR, anti-CYP11A1, anti-3-HSD, and anti-Ser15-phospho-p53
Dutton DJ, Fyie K, Faris P, Brunel L, Emery JH
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress
Br J Diabetes Vasc Dis (2008) 8(2 Suppl):S3441
Archives of Facial Plastic Surgery, 7(1), 27-31
Results indicate that liraglutides potential to reduce CVD risk via improvement of postprandial lipemia